High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model
Cancer Cell International,
Abstract The alpha-fetoprotein receptor (AFPR) is a novel target for cancer therapeutics.